Matsuzaki Haruna, Hatano Masakazu, Iwata Miko, Saito Takeo, Yamada Shigeki
Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, 470-1192, Japan.
Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, 470-1192, Japan.
Neuropsychiatr Dis Treat. 2023 Mar 15;19:615-622. doi: 10.2147/NDT.S402945. eCollection 2023.
Clozapine is more effective than other antipsychotics and is the only antipsychotic approved for treatment-resistant schizophrenia. The objective of this study is to reveal the effect of clozapine on employment using a bidirectional mirror-image model.
This design was a retrospective observational study that investigated the employment status of patients with treatment-resistant schizophrenia based on medical records. The bidirectional mirror-image model consisted of 1) switching from other antipsychotics to clozapine and 2) switching from clozapine to other antipsychotics. The observation period was 1 year for each pre- and post-clozapine initiation and discontinuation.
We included 36 patients in the bidirectional mirror-image model. The regular employment plus employment support rate was significantly higher in the clozapine phase than in the other antipsychotic phase in the bidirectional mirror-image model (30.6% vs 11.1%, = 0.039). The days of regular employment plus employment support were also significantly longer in the clozapine phase (61.3 ± 106.2 vs 24.7 ± 82.7 days, = 0.032). As per the unidirectional mirror-image model, switching to clozapine resulted in significantly higher regular employment plus employment support rates in the clozapine phase than those in the other antipsychotic phase (33.3% vs 10.0%, = 0.039). Switching from clozapine to other antipsychotics did not exhibit significant differences in any outcomes.
The results suggest that clozapine is superior to other antipsychotics with respect to achieving employment in patients with treatment-resistant schizophrenia. However, biases specific to the mirror-image model need to be considered.
氯氮平比其他抗精神病药物更有效,是唯一被批准用于治疗难治性精神分裂症的抗精神病药物。本研究的目的是使用双向镜像模型揭示氯氮平对就业的影响。
本设计为回顾性观察研究,基于病历调查难治性精神分裂症患者的就业状况。双向镜像模型包括:1)从其他抗精神病药物换用氯氮平;2)从氯氮平换用其他抗精神病药物。氯氮平起始和停用前后的观察期均为1年。
我们将36例患者纳入双向镜像模型。在双向镜像模型中,氯氮平治疗阶段的正常就业加就业支持率显著高于其他抗精神病药物治疗阶段(30.6%对11.1%,P = 0.039)。氯氮平治疗阶段的正常就业加就业支持天数也显著更长(61.3±106.2天对24.7±82.7天,P = 0.032)。根据单向镜像模型,换用氯氮平后,氯氮平治疗阶段的正常就业加就业支持率显著高于其他抗精神病药物治疗阶段(33.3%对10.0%,P = 0.039)。从氯氮平换用其他抗精神病药物在任何结局方面均未显示出显著差异。
结果表明,在帮助难治性精神分裂症患者实现就业方面,氯氮平优于其他抗精神病药物。然而,需要考虑镜像模型特有的偏倚。